Research field (2)：
Fetal medicine/Pediatrics
, Hematology and oncology
Papers (32)：
Kaung Htet Nay Win, Yoshihiro Kushida, Keiji Yamana, Sota Iwatani, Makiko Yoshida, Nanako Nino, Cho Yee Mon, Hiroyuki Ohsaki, Shingo Kamoshida, Kazumichi Fujioka, et al. Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant. Stem cell research & therapy. 2024. 15. 1. 147-147
Shotaro Inoue, Kaung Htet Nay Win, Cho Yee Mon, Tomoko Fujikawa, Sayaka Hyodo, Suguru Uemura, Toshiaki Ishida, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, et al. Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high-risk neuroblastoma: A case report. Oncology letters. 2023. 26. 3. 369-369
Nanako Nino, Toshiaki Ishida, Naoko Nakatani, Kyaw San Lin, Kaung Htet Nay Win, Cho Yee Mon, Akihiro Nishimura, Shotaro Inoue, Akihiro Tamura, Nobuyuki Yamamoto, et al. Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients. Heliyon. 2022. 8. 10. e10978
Kyaw San Lin, Suguru Uemura, Khin Kyae Mon Thwin, Naoko Nakatani, Toshiaki Ishida, Nobuyuki Yamamoto, Akihiro Tamura, Atsuro Saito, Takeshi Mori, Daiichiro Hasegawa, et al. Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood. Translational oncology. 2021. 14. 8. 101019-101019
Suguru Uemura, Kyaw San Lin, Khin Kyae Mon Thwin, Naoko Nakatani, Toshiaki Ishida, Nobuyuki Yamamoto, Akihiro Tamura, Atsuro Saito, Takeshi Mori, Daiichiro Hasegawa, et al. Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients. Molecular and clinical oncology. 2021. 15. 1. 137-137
